Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Rigel Pharmaceuticals, Inc.”

373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 373
Index total 30,257
Page 12 / 16

Quick answer

This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

373 results for “Rigel Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 8188276

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  2. US 8178671

    Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  3. US 8168636

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  4. US 8163902

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  5. US 8158621

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  6. US 8148525

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  7. US 8129390

    Carboxamide, sulfonamide and amine compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  8. US 8119809

    AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  9. US 8101627

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  10. US 8097630

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  11. US 8053434

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  12. US 8044054

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted
  13. US 8030483

    Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  14. US 8012965

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  15. US 8012955

    N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  16. US 8008501

    Quinoline compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted
  17. US 7989448

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted
  18. US 7947698

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted May 24, 2011 · Expires May 19, 2031

    granted
  19. US 7935693

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 3, 2011 · Expires Apr 28, 2031

    granted
  20. US 7915273

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted
  21. US 7906644

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted
  22. US 7884119

    Triazole derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted
  23. US 7884111

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Rigel Pharmaceuticals, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted
  24. US 7879856

    Diaminothiazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted